TG THERAPEUTICS, INC. Receivables, Net, Current
TG THERAPEUTICS, INC. (TGTX) had Receivables, Net, Current of $39.32 million as of 2023-09-30, per its 10-Q filed 2023-11-06.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:ReceivablesNetCurrent · last filed 2023-11-06
- 2023-09-30: Receivables, Net, Current $39.32M.
- 2023-06-30: Receivables, Net, Current $17.48M.
- 2023-03-31: Receivables, Net, Current $8.62M.
- 2022-12-31: Receivables, Net, Current $0.00.
| Period end | Receivables, Net, Current |
|---|---|
| 2023-09-30 | $39.32M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $17.48M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $8.62M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-06 |
| 2022-06-30 | $88.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $903.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $1.39M 10-K · filed 2023-03-01 |
| 2021-09-30 | $1.38M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $931.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $771.00K 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |